Blood cancer mystery: scientists hunt for clues to treatment success

NCT ID NCT05440838

Recruiting now Knowledge-focused Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

First seen Mar 20, 2026 · Last updated Apr 28, 2026 · Updated 6 times

Summary

This study looks at 120 adults with certain blood cancers (polycythemia vera, essential thrombocythemia, or pre-myelofibrosis) who are starting their first treatment. Researchers want to find out why some patients respond well to standard drugs (hydroxyurea or pegylated interferon) while others do not. They will analyze genetic and immune markers in the blood to identify factors that predict treatment success, with the goal of personalizing therapy from the start.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Chu Angers
RECRUITING

Angers, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Brest
RECRUITING

Brest, 29606, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Nantes
RECRUITING

Nantes, 44093, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Poitiers
RECRUITING

Poitiers, 86021, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Rennes
RECRUITING

Rennes, 35033, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Tours
RECRUITING

Tours, 37044, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MYELOPROLIFERATIVE NEOPLASM